Strategies for Continued IRT Success During COVID-19

Date Published:

Featured in Journal for Clinical Studies, this article discusses the challenges IRT customers face with the recent COVID-19 pandemic and how to mitigate these potential issues to avoid interrupting ongoing clinical trials.

Discover best practices for:

  • Distribution challenges
  • Screening & enrollment challenges

A properly configured and adaptive IRT system can enable organizations to remain flexible and agile enough to face any challenge. Signant Health’s team of IRT designers, developers, supply experts, and statisticians are available to consult on challenges and best practices.

Download Now